Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
1:43
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Non-Hodgkin Lymphoma Similar Videos
-
Loretta Nastoupil, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
6:24
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Appropriate indications and methods of administration of CNS prophylaxis in aggressive NHL_Victor Orellana-Noia, MD; #DDHO2021
1:36
-
CAR T-cell Therapy in NHL_Noretta Nastoupil, MD; #SOHO2021
20:38